Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.68 USD | -0.13% |
|
-5.89% | +24.10% |
14/05 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
13/05 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.10% | 20Cr | |
+23.69% | 5.27TCr | |
+37.49% | 3.9TCr | |
-9.34% | 3.85TCr | |
+29.54% | 3.04TCr | |
-12.26% | 2.64TCr | |
+11.27% | 2.61TCr | |
+44.97% | 1.42TCr | |
+32.45% | 1.26TCr | |
-5.72% | 1.15TCr |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Transcript : Inovio Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 09, 2020